Clinical and genomic characteristics between DDR germline and somatic mutations in pan-cancer. Programmed cell death ligand 1 (PD-L1) expression landscape and its relationship with tumor mutational ...
Verywell Health on MSN
The TP53 gene and its role in cancer
The TP53 gene is mutated in around 50% of cancer cells, but in addition to its role in tumor suppression, cancer cells ...
Table 1. FDA-Approved Companion Diagnostic Tests and Therapy of Rare Oncogenic Driver Mutations in NSCLC Table 2. Pivotal Trials of Oncogenic Driver Mutations in NSCLC Ceritinib was studied in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback